Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Just Add Wine is an easy way for home cooks to add the taste of red wine to their recipes without having to open a new bottle or go out and purchase a bottle. Just Add Wine comes concentrated in a small sachet and is the equivalent of adding a full glass to your dish.
days to go:
Expired
investment:
£119,970
The Brook makes delicious, exciting, and nutritionally rich meals for a generation that is health-conscious and busy. The restaurant has developed 24 dishes that come with a 100% recyclable retail-ready packaging. The Brook has also set up its production kitchen and secured its 1st retail listings. It has been awarded 3 Great Taste Gold Stars and has been shortlisted for a Great British Food award and a Future Food award. The restaurant has more than 5 years of experience in honing recipes and creating a customer base. The Brook has more than 10k social media followers. 8% of the proceeds will be used for the cost of the raise, 30% for enhancing the team, 37% for supporting the brand and marketing, and 25% in scaling production.
days to go:
Expired
investment:
£265,654
ManíLife is an all-natural Argentinian peanut butter without sugar and palm oil roasted by experts and blended in small batches to create an award-winning taste explosion. The company promotes peanut butter to new heights through the crafted method without the use of added ingredients. ManíLife aims to be the UK's no. 1 peanut butter and eventually the ultimate purveyor of peanut. Till date, the company has achieved 2.4x quarterly sales growth from December 2018 to December 2019. Listed in over 270 Waitrose stores, it is the only peanut butter in history to win 3 Great Taste Stars and over 1 million branded mini pots sold through recipe boxes in the last 2 years and 20,000 Instagram followers. ManíLife will use its proceeds for the support of 2 NPD launch, a major packaging change, and content creation trip back to the farm in Argentina.
days to go:
Expired
investment:
£296,580
Opened in 2014, The Lakes Distillery has sold over 160,000 bottles of their premium gin, vodka, and blended whisky; voted one of the top 5 best new distilleries in the world.
days to go:
Expired
investment:
£1,620,110
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Established by a team from a Michelin star restaurant, The Gaff is a small plate restaurant offering food in contemporary, comfortable, and relaxed surroundings. The first restaurant was opened in May 2019 and aspires for a Michelin Accreditation. The concept of small plate menus was the fourth biggest restaurant concept trend of 2019 which Gaff wants to capture. Gaff has been reviewed in The Good Food Guide 2020 and mentions by prominent food bloggers such as Kavita Favelle. They have also received good customer ratings with over 87% 5-star rating on Res Diary and a 75% rating on TripAdvisor. The funds raised will be utilised to open a second restaurant in Bath and three more around the UK.
days to go:
Expired
investment:
£71,950
